Development of Analytical Method for Ambroxol Hydrochloride and Clenbuterol Hydrochloride Formulation in Korean Pharmaceutical Codex

The Korean Pharmaceutical Codex (KPC) analytical method of ambroxol hydrochloride and clenbuterol hydro- chloride formulation is complicated and needed to carry out multiple processes during the test. 1) To improve the low effi- ciency of analytical procedure that makes pharmaceutical laboratory consume much time and high cost to conduct the test of this formulation, this study was performed for simplifying the pretreatment process and optimizing conditions of the HPLC assay. The analytical procedure using HPLC was developed to establish analytical specification for ambroxol hydro- chloride and clenbuterol hydrochloride formulations. The newly developed analytical method has good linearity (R 2 >0.999), specificity, precision (RSD<1.0%) and the recovery ranges of 98.50~101.84% for ambroxol, 98.29~101.35% for clenbuterol syrup and 98.66~101.71% for clenbuterol tablets. The LOQs were 0.204 μg/ml for ambroxol, 0.021 μg/ml for clenbuterol syrup and 0.073 μg/ml for clenbuterol tablets. 2) The new method was performed with commercially available samples to

[1]  F. Morales-Trejo,et al.  Application of high-performance liquid chromatography–UV detection to quantification of clenbuterol in bovine liver samples , 2013 .

[2]  N. Furusawa,et al.  An isocratic solvent-free mobile phase HPLC-PDA analysis of clenbuterol and ractopamine , 2013 .

[3]  A. R. Rote,et al.  Development of HPTLC method for determination of cefpodoxime proxetil and ambroxol hydrochloride in human plasma by liquid–liquid extraction , 2011, Pharmaceutical methods.

[4]  J. Dharuman,et al.  High performance liquid chromatographic method for the determination of cetirizine and ambroxol in human plasma and urine--a boxcar approach. , 2011, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[5]  Hongyuan Yan,et al.  Determination of clenbuterol in porcine tissues using solid-phase extraction combined with ultrasound-assisted dispersive liquid-liquid microextraction and HPLC-UV detection. , 2011, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[6]  C. Rudolph,et al.  Targeting of the beta(2)-adrenoceptor increases nonviral gene delivery to pulmonary epithelial cells in vitro and lungs in vivo. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[7]  Y. Iwasaki,et al.  Action of N-acylated ambroxol derivatives on secretion of chloride ions in human airway epithelia. , 2009, Biochemical and biophysical research communications.

[8]  K. Shaikh,et al.  Development and validation of a reversed-phase HPLC method for simultaneous estimation of ambroxol hydrochloride and azithromycin in tablet dosage form. , 2008, Journal of pharmaceutical and biomedical analysis.

[9]  A. El-Gindy,et al.  HPLC and chemometrics-assisted UV-spectroscopy methods for the simultaneous determination of ambroxol and doxycycline in capsule. , 2008, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.

[10]  I. Hasegawa,et al.  Ambroxol-induced modification of ion transport in human airway Calu-3 epithelia. , 2006, Biochemical and biophysical research communications.

[11]  S. Han,et al.  Bioequivalence assessment of ambroxol tablet after a single oral dose administration to healthy male volunteers. , 2004, Pharmacological research.

[12]  G. Bazylak,et al.  Simultaneous high-throughput determination of clenbuterol, ambroxol and bromhexine in pharmaceutical formulations by HPLC with potentiometric detection. , 2003, Journal of pharmaceutical and biomedical analysis.

[13]  N. Abdel-Ghani,et al.  Determination of ambroxol hydrochloride in pure solutions and some of its pharmaceutical preparations under batch and FIA conditions. , 2003, Farmaco.

[14]  Y. Jang,et al.  The inhibitory effect of ambroxol on hypochlorous acid-induced tissue damage and respiratory burst of phagocytic cells. , 1999, European journal of pharmacology.

[15]  G. Bray,et al.  Effects of clenbuterol, a β 2-Adrenoceptor agonist, on Macronutrient selection in rats , 1994, Physiology & Behavior.

[16]  P. Badino,et al.  Effects of a β2-agonist (clenbuterol) on cultured human (CG-5) breast cancer cells , 1992 .

[17]  J. Bousquet,et al.  571 Anti-allergic activity of an oral beta-2 agonist, clenbuterol , 1988 .

[18]  J. S. Gutkind,et al.  Interaction between β2- and α2-adrenoceptor responses in the vascular system: effect of clenbuterol , 1986 .

[19]  P. Soubrié,et al.  Does a single priming injection of clenbuterol alter behavioral response to beta-adrenoceptor agonists and antagonists in mice through a time-dependent process? , 1985, European journal of pharmacology.